Terms: = Liver cancer AND PHOX2B, 8929 AND Treatment
2 results:
1. Differences Between Sorafenib and Lenvatinib treatment from Genetic and Clinical Perspectives for Patients with Hepatocellular Carcinoma.
Wang L; Wang L; Xiao B; Cui M; Zhang B
Med Sci Monit; 2022 Apr; 28():e934936. PubMed ID: 35473892
[TBL] [Abstract] [Full Text] [Related]
2. Stability of PCR targets for monitoring minimal residual disease in neuroblastoma.
Stutterheim J; Zappeij-Kannegieter L; Ora I; van Sluis PG; Bras J; den Ouden E; Versteeg R; Caron HN; van der Schoot CE; Tytgat GA
J Mol Diagn; 2012; 14(2):168-75. PubMed ID: 22251610
[TBL] [Abstract] [Full Text] [Related]